Condensed Consolidated Statements of Losses (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating expenses:
Research and development	$ 16	$ 174	$ 38	$ 192
General and administrative	93	110	205	242
Total operating expenses	109	284	243	434
Loss from operations	(109)	(284)	(243)	(434)
Other income (expense):
Gain (loss) on change in fair value of derivative liability	156	(1,060)	(130)	(1,459)
Loss on conversion of debt				(24)
Interest expense, net	(4)	(21)	(8)	(54)
Income (loss) before provision for income taxes	43	(1,365)	(381)	(1,971)
Provision for income taxes
Net income (loss)	$ 43	$ (1,365)	$ (381)	$ (1,971)
Net income (loss) per common share, basic	$ 0.00	$ (0.04)	$ (0.01)	$ (0.06)
Net loss per common share, diluted	$ 0.00	$ (0.04)	$ (0.01)	$ (0.06)
Weighted average shares outstanding, basic	32,132,907	32,132,907	32,132,907	31,500,860
Weighted average shares outstanding, diluted	160,664,535	32,132,907	32,132,907	31,500,860